Pioglitazone 30 mg Tablet Franchise in Mumbai Maharashtra

Antidiabetic PCD Pharma Opportunities in Delhi NCR

Pioglitazone 30 mg Tablet Supply in Chennai Tamil Nadu

Pioglitazone Tablet PCD Franchise in Kolkata West Bengal

Type 2 Diabetes Medicine Distribution in Bangalore Karnataka
Pioglitazone 30 mg Tablet Export Opportunity in Hyderabad Telangana

Home/Products /pioglitazone-30-mg-tablet

Piobot 30 Tablet

Composition : Pioglitazone (30mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹0/-

Please Contact For Best Price

Piobot 30 Tablet contains Pioglitazone 30 mg, a trusted oral antidiabetic agent belonging to the thiazolidinedione class. It improves the body’s response to insulin, thereby enhancing glucose utilization and decreasing hepatic glucose production—key mechanisms in managing type 2 diabetes mellitus.

Pioglitazone 30 mg provides sustained blood-glucose control and is often used in combination therapy with Metformin or Sulfonylureas for patients who require tighter glycemic regulation. It helps reduce fasting and post-meal blood-sugar levels, lowering the risk of long-term diabetic complications.

This formulation is widely prescribed in the antidiabetic and endocrinology segments, making it a valuable option for physicians and healthcare institutions. Its balanced efficacy and safety profile ensure repeat prescriptions and steady market traction.

For PCD pharma franchise partners, third-party manufacturers, and exporters, Piobot 30 Tablet offers excellent business potential. The rising prevalence of type 2 diabetes across India and global markets makes this molecule a profitable addition to any B2B pharma portfolio, backed by strong doctor recommendation and market acceptance.

Read More

About the Product

Piobot 30 Tablet contains Pioglitazone 30 mg, a trusted oral antidiabetic agent belonging to the thiazolidinedione class. It improves the body’s response to insulin, thereby enhancing glucose utilization and decreasing hepatic glucose production—key mechanisms in managing type 2 diabetes mellitus.

Pioglitazone 30 mg provides sustained blood-glucose control and is often used in combination therapy with Metformin or Sulfonylureas for patients who require tighter glycemic regulation. It helps reduce fasting and post-meal blood-sugar levels, lowering the risk of long-term diabetic complications.

This formulation is widely prescribed in the antidiabetic and endocrinology segments, making it a valuable option for physicians and healthcare institutions. Its balanced efficacy and safety profile ensure repeat prescriptions and steady market traction.

For PCD pharma franchise partners, third-party manufacturers, and exporters, Piobot 30 Tablet offers excellent business potential. The rising prevalence of type 2 diabetes across India and global markets makes this molecule a profitable addition to any B2B pharma portfolio, backed by strong doctor recommendation and market acceptance.

Common side effects include weight gain, edema, headache, and fatigue. Rare but serious adverse effects may include heart failure, liver dysfunction, or bladder-related issues. Notify your doctor if you experience swelling, difficulty breathing, or dark urine.

Piobot 30 Tablet is indicated for the treatment of type 2 diabetes mellitus in adults, either as monotherapy or in combination with other antidiabetic medications when diet and exercise alone are insufficient. It helps reduce insulin resistance and stabilizes long-term blood sugar levels.

Take Piobot 30 Tablet exactly as prescribed, preferably at the same time daily. Regular monitoring of blood sugar, liver function, and body weight is essential during treatment. Patients with heart disease, liver problems, or bladder cancer should use this medicine with caution under medical supervision.

Store Piobot 30 Tablet in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep the medication out of reach of children.

Get in Touch